Peter Hulick, MD, Division Head, Center for Medical Genetics
Dr. Peter J. Hulick is the Division Head and a medical geneticist at the NorthShore University HealthSystem Center for Medical Genetics and a Clinical Assistant Professor at the University of Chicago Pritzker School of Medicine.
Dr. Hulick completed his clinical medical genetics residency at Harvard Medical School where his clinical concentrations included connective tissue diseases such as Marfan syndrome and Ehlers-Danlos syndrome while also maintaining a general genetics clinic.
His research during his Harvard genetics training consisted of identifying potential biomarkers of kidney cancer through gene expression profiling of tumor cell lines and the development of a clinical assay to detect kidney cancer at an early stage. He also studied the biological function of the folliculin gene product which, when mutated, causes the kidney cancer predisposition syndrome Birt-Hogg-Dube. During his medical genetics residency, he graduated with a masters in medical science degree from the Harvard Medical Scholars in Clinical Science program which trains individuals for careers in clinical research.
Dr. Hulick received his undergraduate degree in biology from Northwestern University in Evanston, IL and his medical degree from Jefferson Medical College, in Philadelphia, PA. He completed an internal medicine residency at Mayo Clinic, Jacksonville, FL before pursuing his clinical medical genetics training in Boston. Dr. Hulick is board certified in Internal Medicine and Clinical Genetics.
His clinical interests, in addition to general genetic syndromes, include connective tissue disease, cardiovascular, and kidney cancer genetics.
Allison H. West DePersia, MD, Medical Oncologist, Mark R. Neaman Center for Personalized Medicine
Allison H. West DePersia, MD, is a medical oncologist specializing in clinical cancer genetics at NorthShore University HealthSystem’s Mark R. Neaman Center for Personalized Medicine. Dr. DePersia is a member of the High Risk Breast team at NorthShore who has expertise in hereditary cancer syndromes and cancer risk and screening. In her clinical practice she sees patients for cancer genetic testing and provides long term follow up for cancer screening and prevention. Her research includes refining risk assessment and screening approaches for patients who may be at an elevated risk for breast cancer.
Dr. DePersia is board certified in medical oncology and internal medicine. She earned her medical degree from New York University School of Medicine and completed a residency and fellowship at the University of Chicago Hospitals.